Core Viewpoint - ST Unimed (002581.SZ) announced that its wholly-owned subsidiary, Shandong Unimed Tianan Pharmaceutical Co., Ltd. (referred to as "Unimed Tianan"), has recently obtained a Drug Business License issued by the Shandong Provincial Drug Administration, enabling it to legally engage in drug wholesale and distribution activities [1] Group 1 - The acquisition of the Drug Business License marks a significant qualification for Unimed Tianan to operate within the pharmaceutical supply chain [1] - This development is expected to enhance the company's drug sales channels and improve supply chain collaboration efficiency [1] - While this license acquisition supports the overall business development of the company, it is noted that there will be no significant short-term impact on the company's financial performance [1]
ST未名:全资子公司取得药品经营许可证